James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 200 shares at $74.13 ($15K) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Scheduled sale ($15k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $362K | — | Filing → |